Chronix Biomedical Overview
- Year Founded
-
1997
- Status
-
Acquired/Merged
- Employees
-
10
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$50.1M
Chronix Biomedical General Information
Description
Operator of a molecular diagnostics company intended to develop blood tests that help to see if the cancer treatment is effective or if a transplanted organ is being accepted by the patient's body or not. The company's blood test comprises diagnostics test kits that are used for the detection and monitoring of various stages of chronic diseases in human beings and animals, enabling healthcare professionals to easily detect cancer symptoms.
Contact Information
Website
www.chronixbiomedical.comCorporate Office
- 5941 Optical Court
- Suite 201
- San Jose, CA 95138
- United States
Corporate Office
- 5941 Optical Court
- Suite 201
- San Jose, CA 95138
- United States
Chronix Biomedical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 16. Merger/Acquisition | 19-Apr-2021 | $50.1M | Completed | Profitable | ||
| 15. Later Stage VC | 20-Sep-2019 | Completed | Profitable | |||
| 14. Later Stage VC (Series K) | 18-Jul-2017 | Completed | Profitable | |||
| 13. Accelerator/Incubator | Completed | Profitable | ||||
| 12. Later Stage VC (Series J) | 18-May-2017 | Completed | Profitable | |||
| 11. Later Stage VC (Series I) | 31-Oct-2016 | Completed | Profitable | |||
| 10. Later Stage VC (Series H) | 08-Apr-2014 | Completed | Profitable | |||
| 9. Later Stage VC (Series G) | 30-Oct-2012 | Completed | Profitable | |||
| 8. Later Stage VC (Series F) | 11-Mar-2011 | $3M | $16.3M | Completed | Profitable | |
| 7. Later Stage VC (Series E) | 31-May-2010 | $1.74M | $13.3M | Completed | Profitable |
Chronix Biomedical Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series K | ||||||||
| Series J | ||||||||
| Series I | ||||||||
| Series H | ||||||||
| Series G | ||||||||
| Series F | ||||||||
| Series E | ||||||||
| Series D | ||||||||
| Series C | 1,877,778 | $0.000100 | 8% | $0.45 | $0.45 | 1x | $0.15 | 2.42% |
| Series B | 5,045,118 | $0.000100 | 8% | $0.45 | $0.45 | 1x | $0.34 | 2.86% |
Chronix Biomedical Comparisons
Industry
Financing
Details
Chronix Biomedical Competitors (20)
One of Chronix Biomedical’s 20 competitors is CirculoGene, a Venture Capital-Backed company based in Birmingham, AL.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| CirculoGene | Venture Capital-Backed | Birmingham, AL | ||||
| ROCA Test | Formerly VC-backed | Cambridge, United Kingdom | ||||
| Foundation Medicine | Formerly VC-backed | Boston, MA | ||||
| Myriad Genetics | Corporation | Salt Lake City, UT | ||||
| Igenomix USA | Formerly PE-Backed | Paterna, Spain |
Chronix Biomedical Patents
Chronix Biomedical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4409031-A1 | Methods for bias-free quantification of rna | Pending | 29-Sep-2021 | ||
| EP-4409031-A4 | Methods for bias-free quantification of rna | Pending | 29-Sep-2021 | ||
| US-20240401120-A1 | Methods for bias-free quantification of rna | Pending | 29-Sep-2021 | ||
| WO-2023055824-A1 | Methods for bias-free quantification of rna | Inactive | 29-Sep-2021 | ||
| EP-4127214-A2 | Methods for precise and bias-free quantification of cell-free dna | Pending | 27-Mar-2020 | C12Q1/686 |
Chronix Biomedical Signals
Chronix Biomedical Former Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Atlas Accelerator | Venture Capital | Minority | ||
| Boston Harbor Angels | Angel Group | Minority | ||
| Bundesministerium für Bildung und Forschung | Government | |||
| Angel (individual) | Minority | |||
| Keiretsu Forum | Angel Group | Minority |
Chronix Biomedical FAQs
-
When was Chronix Biomedical founded?
Chronix Biomedical was founded in 1997.
-
Where is Chronix Biomedical headquartered?
Chronix Biomedical is headquartered in San Jose, CA.
-
What is the size of Chronix Biomedical?
Chronix Biomedical has 10 total employees.
-
What industry is Chronix Biomedical in?
Chronix Biomedical’s primary industry is Laboratory Services (Healthcare).
-
Is Chronix Biomedical a private or public company?
Chronix Biomedical is a Private company.
-
What is the current valuation of Chronix Biomedical?
The current valuation of Chronix Biomedical is .
-
What is Chronix Biomedical’s current revenue?
The current revenue for Chronix Biomedical is .
-
How much funding has Chronix Biomedical raised over time?
Chronix Biomedical has raised $31M.
-
Who are Chronix Biomedical’s investors?
Atlas Accelerator, Boston Harbor Angels, Bundesministerium für Bildung und Forschung, , and Keiretsu Forum are 5 of 11 investors who have invested in Chronix Biomedical.
-
Who are Chronix Biomedical’s competitors?
CirculoGene, ROCA Test, Foundation Medicine, Myriad Genetics, and Igenomix USA are some of the 20 competitors of Chronix Biomedical.
-
When was Chronix Biomedical acquired?
Chronix Biomedical was acquired on 19-Apr-2021.
-
Who acquired Chronix Biomedical?
Chronix Biomedical was acquired by Insight Molecular Diagnostics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process